Care of the brain-dead organ donor

Current Anaesthesia and Critical Care

Volumn 18, Issue 5-6, 2007, Pages 284-294

  Linos, Konstantinos ^a   Fraser, John ^a   Freeman, William D ^b   Foot, Carole ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b MAYO CLINIC   (United States)

Author keywords

Brain; Brain dead; Brain death; Death; Intensive care

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DESMOPRESSIN; DEXAMETHASONE; DIURETIC AGENT; ELECTROLYTE; ESMOLOL; FLUDROCORTISONE; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INSULIN; LABETALOL; LIOTHYRONINE; METHYLPREDNISOLONE; NICARDIPINE; NITROPRUSSIDE SODIUM; VASOPRESSIN;

ADRENAL INSUFFICIENCY; ARTICLE; BRAIN DEATH; DIABETES INSIPIDUS; DISEASE SEVERITY; DRUG DOSE TITRATION; ELECTROLYTE DISTURBANCE; EMOTIONALITY; FAMILY ATTITUDE; FAMILY COUNSELING; HEAD INJURY; HEALTH CARE PERSONNEL; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; IMMUNOPATHOLOGY; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; KIDNEY ALLOGRAFT; LIVER GRAFT; LOADING DRUG DOSE; LUNG EDEMA; MEDICAL DOCUMENTATION; MEDICAL ETHICS; NERVOUS SYSTEM INJURY; NEUROENDOCRINE DISEASE; ORGAN DONOR; ORGAN PERFUSION; PATIENT ATTITUDE; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SPINAL REFLEX; STROKE; STUNNED HEART MUSCLE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 36549052588     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.09.003     Document Type: Article

References (110)

1. Tuttle-Newhall J.E., Collins B.H., Kuo P.C., and Schoeder R. Organ donation and treatment of the multi-organ donor. Curr Probl Surg 40 5 (2003) 266-310
2. Channel 10 television network Australia, 〈www.ten.com.au/ten/the-ultimate-donation-synopsis.html〉, [accessed 12.07.07].
3. Arbour R. Clinical management of the organ donor. AACN Clin Issues 16 4 (2005) 551-580 [quiz 600-1]
4. Kutsogiannis D.J., Pagliarello G., Doig C., Ross H., and Shemie S.D. Medical management to optimize donor organ potential: review of the literature. Can J Anaesth 53 8 (2006) 820-830
5. Organ procurement and transplantation network (OPTN), 〈www.optn.org〉, [accessed 12.07.07].
6. A definition of irreversible coma. Report of the ad hoc committee of the Harvard Medical School to examine the definition of brain death. JAMA 5 August 1968; 205(6): 337-40.
7. Mollaret P., and Goulon M. The depassed coma (preliminary memoir). Rev Neurol (Paris) 101 (1959) 3-15 [French]
8. Greenblatt S.H. Harvey Cushing's paradigmatic contribution to neurosurgery and the evolution of his thoughts about specialization. Bull Hist Med 77 4 (2003) 789-822
9. Cushing H. Studies in intracranial physiology and surgery; the third circulation, the hypophysics, the gliomas (1926), Oxford University Press, London
10. Lopez-Navidad A., Cabalerro F., Guirado L., et al. The medical-nursing team specialized in the maintenance of the brain-dead heart-beating organ donor exclusively dedicated to caring for the donor reduces donor loss from asystolia to zero. Transplant Proc 34 (2002) 20-22
11. Karcioglu O., Ayrik C., and Erbil B. The brain-dead patient or a flower in the vase? The emergency department approach to the preservation of the organ donor. Eur J Emerg Med 10 1 (2003) 52-57
12. Rosendale J.D., Kauffman H.M., McBride M.A., Chabalewski F.L., Zaroff J.G., Garrity E.R., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75 4 (2003) 482-487
13. Rosendale J.D., Chabalewski F.L., McBride M.A., Garrity E.R., Rosengard B.R., Delmonico F.L., et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2 8 (2002) 761-768
14. Angel L.F., Levine D.J., Restrepo M.I., Johnson S., Sako E., Carpenter A., et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 174 6 (2006) 710-716
15. Salim A., Martin M., Brown C., Rhee P., Demetriades D., and Belzberg H. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma 61 2 (2006) 429-433 [discussion 433-5]
16. Ullah S., Zabala L., Watkins B., and Schmitz M.L. Cardiac organ donor management. Perfusion 21 2 (2006) 93-98
17. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 29 8 (1997) 3770-3772
18. Smith M. Physiologic changes during brain stem death-lessons for management of the organ donor. J Heart Lung Transplant 23 9 Suppl. (2004) S217-S222
19. Chen E.P., Bittner H.B., Kendall S.W., and Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 24 8 (1996) 1352-1359
20. Powner D.J., Hendrich A., Nyhuis A., and Strate R. Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant 11 6 (1992) 1046-1053
21. Marshall V.C. Pathophysiology of brain death: effects on allograft function. Transplant Proc 33 1-2 (2001) 845-846
22. Pratschke J., Wilhelm M.J., Kusaka M., Basker M., Cooper D.K., Hancock W.W., et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 67 3 (1999) 343-348
23. Delgado D.H., Rao V., and Ross H.J. Donor management in cardiac transplantation. Can J Cardiol 18 11 (2002) 1217-1223
24. Stoica S., Satchinthananda D., and Large S. Current perspectives in donor management. Z Herz-Thorax-GefaBchir 16 Suppl. 1 (2002) 1/20-1/26
25. Avlonitis V.S., Fisher A.J., Kirby J.A., and Dark J.H. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 75 12 (2003) 1928-1933
26. Powner D.J., and Darby J.M. Management of variations in blood pressure during care of organ donors. Prog Transplant 10 1 (2000) 25-30 [quiz 31-2]
27. Rosengard B.R., Feng S., Alfrey E.J., Zaroff J.G., Emond J.C., Henry M.L., et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2 8 (2002) 701-711
28. Hunt S.A., Baldwin J., Baumgartner W., Bricker J.T., Costanzo M.R., Miller L., et al. Cardiovascular management of a potential heart donor: a statement from the Transplantation Committee of the American College of Cardiology. Crit Care Med 24 9 (1996) 1599-1601
29. Debaveye Y.A., and Van den Berghe G.H. Is there still a place for dopamine in the modern intensive care unit?. Anesth Analg 98 2 (2004) 461-468
30. Yamamoto K., Okubo S., Naito M., Fujii T., Hiramori K., Kunieda T., et al. Successfully operated case of recurrent pulmonary thromboembolism with disabling chronic cor pulmonale. Kokyu To Junkan 34 5 (1986) 565-570 [Japanese]
31. Pennefather S.H., Bullock R.E., Mantle D., and Dark J.H. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 59 1 (1995) 58-62
32. Razek T., Olthoff K., and Reilly P.M. Issues in potential organ donor management. Surg Clin North Am 80 3 (2000) 1021-1032
33. Howlett T.A., Keogh A.M., Perry L., Touzel R., and Rees L.H. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation 47 5 (1989) 828-834
34. Gramm H.J., Meinhold H., Bickel U., Zimmermann J., von Hammerstein B., Keller F., et al. Acute endocrine failure after brain death?. Transplantation 54 5 (1992) 851-857
35. Lagiewska B., Pacholczyk M., Szostek M., Walaszewski J., and Rowinski W. Hemodynamic and metabolic disturbances observed in brain-dead organ donors. Transplant Proc 28 1 (1996) 165-166
36. Phongsamran P.V. Critical care pharmacy in donor management. Prog Transplant 14 2 (2004) 105-111 quiz 112-3
37. Erratum in: Prog Transplant 2004;14(3):264.
38. Zaroff J.G., Rosengard B.R., Armstrong W.F., Babcock W.D., D'Alessandro A., Dec G.W., et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, VA. Circulation 106 7 (2002) 836-841
39. Novitzky D., Cooper D.K., and Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 43 6 (1987) 852-854
40. Novitzky D., Cooper D.K., Morrell D., and Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 45 1 (1988) 32-36
41. Novitzky D., Cooper D.K., Chaffin J.S., Greer A.E., DeBault L.E., and Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 49 2 (1990) 311-316
42. Sztark F., Thicoipe M., Lassie P., Petitjean M.E., and Dabadie P. Mitochondrial energy metabolism in brain-dead organ donors. Ann Transplant 5 4 (2000) 41-44
43. Rosendale J.D., Kauffman H.M., McBride M.A., Chabalewski F.L., Zaroff J.G., Garrity E.R., et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75 8 (2003) 1336-1341
44. Jonas M., and Oduro A. Management of the multi-organ donor. In: Higgins R.S., Sanchez J.A., Lorber M.I., et al. (Eds). The multi-organ donor: selection and management (1997), Blackwell Science, Malden 123-139
45. Masson F., Thicoipe M., Gin H., de Mascarel A., Angibeau R.M., Favarel-Garrigues J.F., et al. The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation 56 2 (1993) 363-367
46. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 7093 (1997) 1512-1515
47. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
48. Finney S.J., Zekveld C., Elia A., and Evans T.W. Glucose control and mortality in critically ill patients. JAMA 290 15 (2003) 2041-2047
49. Zivna H., Zivny P., Navratil P., Palicka V., Cerny V., Holeckova M., et al. The role of cytokines and antioxidant status in graft quality prediction. Transplant Proc 31 5 (1999) 2094
50. Amado J.A., Lopez-Espadas F., Vazquez-Barquero A., Salas E., Riancho J.A., Lopez-Cordovilla J.J., et al. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism 44 6 (1995) 812-816
51. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., and Large S.R. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 14 4 (1995) 734-742
52. Macmillan C.S., Grant I.S., and Andrews P.J. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?. Intensive Care Med 28 8 (2002) 1012-1023
53. Sutherland A.J., Ware R.S., Winterford C., and Fraser J.F. The endothelin axis and gelatinase activity in alveolar macrophages after brain-stem death injury: a pilot study. J Heart Lung Transplant 26 10 (2007) 1040-1047
54. Aziz T.M., El-Gamel A., Saad R.A., Migliore M., Campbell C.S., and Yonan N.A. Pulmonary vein gas analysis for assessing donor lung function. Ann Thorac Surg 73 5 (2002) 1599-1604 [discussion 1604-5]
55. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E.P., Cooper J.D., et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 109 6 (1995) 1075-1079 [discussion 1079-80]
56. Straznicka M., Follette D.M., Eisner M.D., Roberts P.F., Menza R.L., and Babcock W.D. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 124 2 (2002) 250-258
57. Harjula A., Baldwin J.C., Starnes V.A., Stinson E.B., Oyer P.E., Jamieson S.W., et al. Proper donor selection for heart-lung transplantation. The Stanford experience. J Thorac Cardiovasc Surg 94 6 (1987) 874-880
58. Avlonitis V.S., Krause A., Luzzi L., Powell H., Phillips J.A., Corris P.A., et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 24 4 (2003) 601-607
59. Brower R.G., Lanken P.N., MacIntyre N., Matthay M.A., Morris A., Ancukiewicz M., et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351 4 (2004) 327-336
60. Gabbay E., Williams T.J., Griffiths A.P., Macfarlane L.M., Kotsimbos T.C., Esmore D.S., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160 1 (1999) 265-271
61. Follette D.M., Rudich S.M., and Babcock W.D. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 17 4 (1998) 423-429
62. McElhinney D.B., Khan J.H., Babcock W.D., and Hall T.S. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant 15 1 (2001) 68-71
63. Rodrigo G.J., Rodrigo C., and Hall J.B. Acute asthma in adults: a review. Chest 125 3 (2004) 1081-1102
64. Melk A., Gourishankar S., and Halloran P. Long-term effects of nonimmune tissue injury in renal transplantation. Curr Opin Organ Transplant 7 (2002) 171-177
65. Nagareda T., Kinoshita Y., Tanaka A., Takeda M., Sakano T., Yawata K., et al. Clinicopathology of kidneys from brain-dead patients treated with vasopressin and epinephrine. Kidney Int 43 6 (1993) 1363-1370
66. Pratschke J., Wilhelm M.J., Kusaka M., Beato F., Milford E.L., Hancock W.W., et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 232 2 (2000) 263-271
67. Kusaka M., Pratschke J., Wilhelm M.J., Ziai F., Zandi-Nejad K., Mackenzie H.S., et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 69 3 (2000) 405-410
68. Szostek M., Gaciong Z., Danielelewicz R., Lagiewska B., Pacholczyk M., Chmura A., et al. Influence of thyroid function in brain stem death donors on kidney allograft function. Transplant Proc 29 8 (1997) 3354-3356
69. Walaszewski J., Rowinski W., Pacholczyk M., Lagiewska B., Cajzner S., Chmura A., et al. Multiple risk factor analysis of delayed graft function (ATN) after cadaveric transplantation: positive effect of lidocaine donor pretreatment. Transplant Proc 23 5 (1991) 2475-2476
70. Port F.K., Bragg-Gresham J.L., Metzger R.A., Dykstra D.M., Gillespie B.W., Young E.W., et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 74 9 (2002) 1281-1286
71. Carter J.T., Lee C.M., Weinstein R.J., Lu A.D., Dafoe D.C., and Alfrey E.J. Evaluation of the older cadaveric kidney donor: the impact of donor hypertension and creatinine clearance on graft performance and survival. Transplantation 70 5 (2000) 765-771
72. Sola R., Guirado L., Diaz J.M., Lopez-Navidad A., Caballero F., and Gich I. Elderly donor kidney grafts into young recipients: results at 5 years. Transplantation 73 10 (2002) 1673-1675
73. Becker Y.T., Leverson G.E., D'Alessandro A.M., Sollinger H.W., and Becker B.N. Diabetic kidneys can safely expand the donor pool. Transplantation 74 1 (2002) 141-145
74. Ojo A.O., Hanson J.A., Meier-Kriesche H., Okechukwu C.N., Wolfe R.A., Leichtman A.B., et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 12 3 (2001) 589-597
75. Clavien P.A., Harvey P.R., and Strasberg S.M. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53 5 (1992) 957-978
76. Brokelman W., Stel A.L., and Ploeg R.J. Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era. Transplant Proc 31 5 (1999) 2087-2090
77. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., Stegall M.D., Pirsch J.D., Hoffmann R.M., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 4 (1993) 807-813
78. Roelsgaard K., Botker H.E., Stodkilde-Jorgensen H., Andreasen F., Jensen S.L., and Keiding S. Effects of brain death and glucose infusion on hepatic glycogen and blood hormones in the pig. Hepatology 24 4 (1996) 871-875
79. Heyland D.K., Dhaliwal R., Drover J.W., Gramlich L., and Dodek P. Canadian Critical Care Clinical Practice Guidelines Committee, Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 27 5 (2003) 355-373
80. Figueras J., Busquets J., Grande L., Jaurrieta E., Perez-Ferreiroa J., Mir J., et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation 61 3 (1996) 410-413
81. Totsuka E., Dodson F., Urakami A., Moras N., Ishii T., Lee M.C., et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transplant Surg 5 5 (1999) 421-428
82. Truog R.D., Cist A.F., Brackett S.E., Burns J.P., Curley M.A., Danis M., et al. Recommendations for end-of-life care in the intensive care unit: the Ethics Committee of the Society of Critical Care Medicine. Crit Care Med 29 12 (2001) 2332-2348
83. Morenski J.D., Oro J.J., Tobias J.D., and Singh A. Determination of death by neurological criteria. J Intensive Care Med 18 4 (2003) 211-221
84. Imanaka H., Nishimura M., Takeuchi M., Kimball W.R., Yahagi N., and Kumon K. Autotriggering caused by cardiogenic oscillation during flow-triggered mechanical ventilation. Crit Care Med 28 2 (2000) 402-407
85. Hill L.L., and Pearl R.G. Flow triggering, pressure triggering, and autotriggering during mechanical ventilation. Crit Care Med 28 2 (2000) 579-581
86. Fenstermacher D., and Hong D. Mechanical ventilation: what have we learned?. Crit Care Nurs Q 27 3 (2004) 258-294
87. Holt T.B. Cardiogenic triggering observed in a patient with acute respiratory distress syndrome. Respir Care 46 10 (2001) 1054-1055
88. Jenkins D.H., Reilly P.M., and Schwab C.W. Improving the approach to organ donation: a review. World J Surg 23 7 (1999) 644-649
89. Parker M., and Shemie S.D. Pro/con ethics debate: should mechanical ventilation be continued to allow for progression to brain death so that organs can be donated?. Crit Care 6 5 (2002) 399-402
90. Mason S., Barrow H., Phillips A., Eddison G., Nelson A., Cullum N., et al. Brief report on the experience of using proxy consent for incapacitated adults. J Med Ethics 32 1 (2006) 61-62
91. Dunstan G.R. The ethics of organ donation. Br Med Bull 53 4 (1997) 921-939
92. Beauchamp T., and Childress J. Principles of biomedical ethics. 3rd ed. (1989), Oxford University Press, New York
93. Reiner M., Cornell D., and Howard R.J. Development of a successful non-heart-beating organ donation program. Prog Transplant 13 3 (2003) 225-231
94. Richards B., and Rogers W.A. Organ donation after cardiac death: legal and ethical justifications for antemortem interventions. Med J Aust 187 3 (2007) 168-170
95. Ligtenberg J.J., and Zijlstra J.G. The relative adrenal insufficiency syndrome revisited: which patients will benefit from low-dose steroids?. Curr Opin Crit Care 10 6 (2004) 456-460
96. Ullah S., Zabala L., Watkins B., and Schmitz M.L. Cardiac organ donor management. Perfusion 21 2 (2006) 93-98
97. Spittler J.F., Wortmann D., von During M., and Gehlen W. Phenomenological diversity of spinal reflexes in brain death. Eur J Neurol 7 3 (2000) 315-321
98. Jordan J.E., Dyess E., and Cliett J. Unusual spontaneous movements in brain-dead patients. Neurology 35 7 (1985) 1082
99. Dosemeci L., Cengiz M., Yilmaz M., and Ramazanoglu A. Frequency of spinal reflex movements in brain-dead patients. Transplant Proc 36 1 (2004) 17-19
100. Christie J.M., O'Lenic T.D., and Cane R.D. Head turning in brain death. J Clin Anesth 8 2 (1996) 141-143
101. Saposnik G., Bueri J.A., Maurino J., Saizar R., and Garretto N.S. Spontaneous and reflex movements in brain death. Neurology 54 1 (2000) 221-223
102. Heytens L., Verlooy J., Gheuens J., and Bossaert L. Lazarus sign and extensor posturing in a brain-dead patient. Case report. J Neurosurg 71 3 (1989) 449-451
103. Hanna J.P., and Frank J.I. Automatic stepping in the pontomedullary stage of central herniation. Neurology 45 5 (1995) 985-986
104. McNair N.L., and Meador K.J. The undulating toe flexion sign in brain death. Mov Disord 7 4 (1992) 345-347
105. Marti-Fabregas J., Lopez-Navidad A., Caballero F., and Otermin P. Decerebrate-like posturing with mechanical ventilation in brain death. Neurology 54 1 (2000) 224-227
106. Wijdicks E.F. The diagnosis of brain death. N Engl J Med 344 16 (2001) 1215-1221
107. Wijdicks E.F., Manno E.M., and Holets S.R. Ventilator self-cycling may falsely suggest patient effort during brain death determination. Neurology 65 5 (2005) 774
108. Wood K.E., Becker B.N., McCartney J.G., D'Alessandro A.M., and Coursin D.B. Care of the potential organ donor. N Engl J Med 351 26 (2004) 2730-2739
109. Peterson B.T., Ross J.C., and Brigham K.L. Effect of naloxone on the pulmonary vascular responses to graded levels of intracranial hypertension in anesthetized sheep. Am Rev Respir Dis 128 6 (1983) 1024-1029
110. Chen B., and Liu Y.S. Randomized double-blind clinical trial of moderate dosage naloxone in acute moderate and severe traumatic brain injury. Hunan Yi Ke Da Xue Xue Bao 27 1 (2002) 58-60 [Chinese]